Can a tracheostomy be decannulated later in a boy with Duchenne muscular dystrophy if his respiratory function stabilizes?

Can Tracheostomy Be Reversed in Duchenne Muscular Dystrophy?

Yes, tracheostomy can potentially be reversed (decannulated) in boys with Duchenne muscular dystrophy, though this is uncommon and requires careful evaluation—however, the more important clinical reality is that modern respiratory management strategies using continuous noninvasive ventilation (NIV) can often avoid tracheostomy entirely, and patients who are already tracheostomized can sometimes be successfully decannulated to NIV. 1, 2

Evidence for Decannulation in DMD

Successful Decannulation Cases

Research demonstrates that decannulation is feasible in DMD patients:

• Eight tracheostomized DMD patients were successfully decannulated to NIV in one series 2
• Five patients with no breathing tolerance were extubated or decannulated to continuous noninvasive ventilation 1
• Thirty-one consecutive unweanable intubated patients were extubated to NIV plus mechanically assisted cough without requiring tracheostomy 2

These outcomes occurred when patients had access to:

• Continuous noninvasive ventilation (up to 24 hours/day)
• Mechanically assisted coughing protocols
• Oximetry monitoring to maintain SpO₂ ≥95%

Critical Prerequisites for Decannulation

According to ATS guidelines on pediatric tracheostomy care, successful decannulation requires 3:

Mandatory endoscopic evaluation before decannulation to identify:

• Granulation tissue above the stoma
• Unresolved subglottic narrowing
• Tracheomalacia
• Other anatomic or functional obstructions

Timing considerations:

• Most decannulation failures occur within 12-36 hours 3
• In patients with minimal respiratory reserve (like DMD), consider delaying decannulation until after high-risk respiratory infection season 3
• The stoma typically closes spontaneously within hours or days, making emergency recannulation difficult 3

The Modern DMD Respiratory Management Paradigm

Avoiding Tracheostomy Entirely

The contemporary approach prioritizes avoiding tracheostomy through aggressive noninvasive support 4:

24-hour NIV is a safe alternative to tracheostomy:

• Patients can use nocturnal mask ventilation combined with daytime mouthpiece ventilation (MPV) 5
• Mean survival on 24-hour NIV has been 5.7 years (range 0.17-12 years) 5
• Continuous NIV dependence averaged 7.4 ± 6.1 years in one cohort 2

Survival benefits without tracheostomy:

• Patients using long-term mechanical ventilatory support (primarily NIV) survived to 25.3 years versus 19.29 years for those refusing ventilation 4
• None of 34 full-time NIV users with access to mechanically assisted cough protocols died from respiratory complications during 5.4 ± 4.0 years of follow-up 1

When Tracheostomy Should Be Considered

According to the most recent UK guidelines 6:

Tracheostomy formation should only be undertaken following advice from a specialist center and is reserved for:

• Failure of NIV despite optimization
• Inability to maintain adequate ventilation noninvasively
• Severe bulbar dysfunction preventing NIV use

However, even in acute respiratory failure:

• NIV is the initial treatment of choice 6
• In single organ respiratory failure, prospects of recovery are good
• Invasive ventilation should be discussed with the specialist respiratory team
• Early tracheostomy during weaning has NOT been shown to improve mortality or length of critical care admission 6

Practical Algorithm for Your Patient

If Tracheostomy Has Already Been Placed:

1. Optimize respiratory support:

   • Ensure access to mechanically assisted cough device (MI-E)
   • Maintain SpO₂ ≥95% at all times
   • Aggressive airway clearance protocols

2. Assess candidacy for decannulation:

   • Perform endoscopic evaluation of airway
   • Evaluate for anatomic obstructions (granulation tissue, subglottic stenosis)
   • Assess bulbar function
   • Ensure availability of continuous NIV equipment and trained caregivers

3. If decannulation attempted:

   • Must be done in specialist center with experience in DMD
   • Plan for immediate transition to continuous NIV + mechanically assisted cough
   • Close monitoring for 12-36 hours post-decannulation
   • Have emergency recannulation equipment immediately available

If Tracheostomy Is Being Considered:

Strongly pursue alternatives first:

• Trial of continuous NIV (nocturnal mask + daytime mouthpiece ventilation)
• Mechanically assisted cough protocol
• Consultation with specialist neuromuscular respiratory center
• Consider that 24-hour NIV has been successfully used for years in DMD patients 2, 5

Critical Caveats

Progressive nature of DMD: Unlike other conditions requiring tracheostomy, DMD is relentlessly progressive. Even if respiratory function temporarily "stabilizes," the underlying neuromuscular disease continues to advance 4. This makes true long-term decannulation less likely than in other pediatric populations.

Bulbar involvement: Progressive bulbar weakness in DMD may eventually limit the effectiveness of NIV, particularly mouthpiece ventilation 7. This is a key factor in determining whether decannulation is feasible.

Quality of life considerations: Multiple studies show that physicians significantly underestimate the quality of life perceived by ventilator-dependent DMD patients 4. Discussions about ventilation options (including potential decannulation) should be repeated throughout the disease course and incorporate patient/family values 4.

The 2025 ATS guideline on pediatric tracheostomy 8 emphasizes that capped polysomnography can predict decannulation success, with higher failure rates (14%) when PSG is omitted versus 2-3% when included, though this evidence comes from mixed pediatric populations, not DMD-specific cohorts.